Dr. Tsung specializes in laparoscopic and robotic surgery. He focuses on caring for patients with liver, bile duct and pancreas cancers, according to the Oct. 4 Xenetic news release.
Dr. Tsung currently serves as the chair of the department of surgery at the Charlottesville-based University of Virginia School of Medicine. He earned his medical degree at Brooklyn, N.Y.-based SUNY Health Science Center.
“Dr. Tsung brings decades of experience across both research and patient care which provides a valuable perspective to our team and significant insight as we advance our innovative immune-oncology technologies, Xenetic CEO Jeffery Eisenberg said. “We remain committed to driving our DNase-based oncology platform forward, and we expect Dr. Tsung to be a key contributor to Xenetic in identifying unmet medical needs and creating pre-clinical and clinical development strategies. We are excited to leverage Dr. Tsung’s expertise and continue building momentum.”
